Lomustine With and Without Reirradiation for First Progression of Glioblastoma: a Randomized Phase III Study
Clinical trial NCT05904119 · RECRUITING
Trial details
- NCT number
- NCT05904119
- Sponsor
- European Organisation for Research and Treatment of Cancer - EORTC
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-15
- Primary completion
- 2027-09-01
- Enrollment
- 411
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.